Comments on: Polymorphisms indicating risk of inflammatory bowel disease or antigenicity to anti-TNF drugs as biomarkers of response in children

  1. Zapata-Cobo, P.
  2. Salvador-Matín, S.
  3. Velasco, M.
  4. Palomino, L.M.
  5. Clemente, S.
  6. Segarra, O.
  7. Moreno-Álvarez, A.
  8. Fernández-Lorenzo, A.
  9. Pérez-Moneo, B.
  10. Montraveta, M.
  11. Sánchez, C.
  12. Tolín, M.
  13. Loverdos, I.
  14. Fobelo, M.J.
  15. Navas-López, V.M.
  16. Magallares, L.
  17. García-Romero, R.
  18. Sánchez-Hernández, J.G.
  19. Rodríguez, A.
  20. Bossacoma, F.
  21. Balboa, M.J.
  22. Salcedo, E.
  23. Sanjurjo-Sáez, M.
  24. López-Fernández, L.A.
Aldizkaria:
Pharmacological Research

ISSN: 1096-1186,  1043-6618

Argitalpen urtea: 2023

Alea: 196

Mota: Gutuna

DOI: 10.1016/J.PHRS.2023.106938 GOOGLE SCHOLAR lock_openSarbide irekia editor

Garapen Iraunkorreko Helburuak

Datuen iturria: Scopus